Insider Transactions in Q1 2023 at Fortress Biotech, Inc. (FBIO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2023
|
Lu Lucy Director |
BUY
Open market or private purchase
|
Direct |
11,976
+8.24%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
J Jay Lobell Director |
BUY
Open market or private purchase
|
Direct |
299,401
+15.47%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Open market or private purchase
|
Direct |
2,395,209
+13.5%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Eric K Rowinsky Director |
BUY
Open market or private purchase
|
Direct |
11,976
+1.27%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
Michael S Weiss Director |
BUY
Open market or private purchase
|
Direct |
1,197,604
+7.51%
|
$0
$0.84 P/Share
|
|
Feb 10
2023
|
David Jin Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
35,928
+2.44%
|
$0
$0.84 P/Share
|
|
Jan 01
2023
|
Jimmie Harvey Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.52%
|
-
|
|
Jan 01
2023
|
Malcolm Hoenlein Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+8.54%
|
-
|
|
Jan 01
2023
|
Dov Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+10.52%
|
-
|
|
Jan 01
2023
|
J Jay Lobell Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+6.96%
|
-
|
|
Jan 01
2023
|
Kevin Lorenz Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+13.71%
|
-
|
|
Jan 01
2023
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.8%
|
-
|
|
Jan 01
2023
|
Michael S Weiss Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,219,294
+8.25%
|
-
|
|
Jan 01
2023
|
Lu Lucy Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+29.17%
|
-
|
|
Jan 01
2023
|
Lindsay A Md Rosenwald PRESIDENT, CEO & CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
1,219,294
+8.6%
|
-
|